ClinVar Miner

Submissions for variant NM_000834.5(GRIN2B):c.3534C>T (p.His1178=)

gnomAD frequency: 0.39095  dbSNP: rs1806191
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Athena Diagnostics RCV000711874 SCV000842284 benign not provided 2017-04-20 criteria provided, single submitter clinical testing
Ambry Genetics RCV002312131 SCV000846164 benign Inborn genetic diseases 2016-02-09 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Labcorp Genetics (formerly Invitae), Labcorp RCV001517087 SCV001725500 benign Intellectual disability, autosomal dominant 6; Developmental and epileptic encephalopathy, 27 2024-02-01 criteria provided, single submitter clinical testing
GeneDx RCV000711874 SCV001904846 benign not provided 2015-03-03 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001701508 SCV001933972 benign Developmental and epileptic encephalopathy, 27 2021-08-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001701754 SCV001933973 benign Intellectual disability, autosomal dominant 6 2021-08-10 criteria provided, single submitter clinical testing
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan RCV000117197 SCV005087378 benign not specified 2024-07-15 criteria provided, single submitter clinical testing This variant is classified as Benign based on local population frequency. This variant was detected in 78% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 73. Only high quality variants are reported.
Breakthrough Genomics, Breakthrough Genomics RCV000711874 SCV005233643 benign not provided criteria provided, single submitter not provided
Genetic Services Laboratory, University of Chicago RCV000117197 SCV000151361 likely benign not specified no assertion criteria provided clinical testing Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000117197 SCV001741545 benign not specified no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000117197 SCV001953163 benign not specified no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.